4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org

What Is BioGenerator?

BioGenerator is an evergreen investor that creates, grows, and funds innovative companies and talented entrepreneurs in the St. Louis region. BioGenerator identifies and de-risks commercially promising innovations and services; advises innovators and entrepreneurs; recruits and supports entrepreneurial talent; makes staged investments grounded in rigorous due diligence; and offers access to enabling lab space and capital equipment. We position companies to navigate the unique challenges of early-stage bioscience company development.

BioGenerator is the investment arm of BioSTL

Adarza is a next-generation multiplex immunoassay product company focused on applications in life science tools and the in vitro diagnostics markets. Adarza’s products and services utilize its proprietary Arrayed Imaging Reflectometry™ (“AIR”) detection platform that is capable of rapid identification and quantification and offers key performance benefits in multiplexing, sensitivity, speed, sample size, dynamic range, and ease of use while affording industry-leading low cost. The AIR platform addresses many commercial applications, including disease biomarkers, personalized medicine, drug and vaccine development, allergy, immunology, and infectious diseases research.

Our Companies

The BioGenerator portfolio is a compilation of companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

Our Companies

The BioGenerator portfolio includes companies within the health and plant sciences including therapeutics, diagnostics, medical devices, research tools, agriculture and IT.

BioGenerator Company Canopy Biosciences Acquired by Bruker09/11/2020

COVID-19 treatment developed in St. Louis’ BioSTL Building to begin in-patient studies06/17/2020

BioGenerator-supported VaxNewMo Earns $3 Million Grant to Advance Vaccine Development02/20/2020

BioGenerator Company Adarza BioSystems Raises $25M Series D to Launch Commercial Platform02/18/2020

BioGenerator Invests $3.2 Million in 16 St. Louis Bioscience Companies01/21/2020

St. Louis’ Phas3 Lands Paid Pilot at Colorado Hospitals12/17/2019

BioGenerator Company Canopy Biosciences buys California analysis firm12/13/2019

BioGenerator Company Readout Health Produces New Class 1 Medical Device to Easily Track Nutritional Ketosis12/12/2019

See All News

What Others Are Saying

Joseph Monahan
Jon Root
Matt Crisp

Stay Updated

Stay up to date with the latest BioGenerator news and details.